Lightning Flash™ is the most advanced mechanical thrombectomy system on the market to address venous and pulmonary thrombus Next generation technology combines superior catheter design with the latest ...

Adam Elsesser, Chairman and CEO, highlighted that Penumbra achieved total revenue of $324.1 million in Q1 2025, representing year-over-year growth of 16.3% on a reported basis and 16.9% in constant ...

Latest STRIKE-PE data show that computer assisted vacuum thrombectomy (CAVT) for the treatment of pulmonary embolism is safe and effective at reducing right heart strain; it also improved clinical and ...

Penumbra, Inc. (NYSE:PEN) ranks among the best medical device stocks to invest in. Needham raised Penumbra, Inc.

Penumbra is Friday's IBD Stock Of The Day. After pulling back somewhat following a post-earnings breakout, Penumbra stock is eyeing two potential new entries. The Alameda, Calif.-based medical company ...

Penumbra, Inc. PEN recently received FDA clearance for the RED 62 Reperfusion Catheter. Following this regulatory go-ahead, the company has also initiated commercial availability of the catheter ...

Penumbra, Inc. (NYSE:PEN), a leader in the medical technology sector specializing in thrombectomy devices, has been garnering attention from analysts due to its strong performance and promising ...

Penumbra, Inc. (NYSE:PEN) is one of the 11 Best Mid-cap Healthcare Stocks to Buy According to Hedge Funds. The company announced the completion of enrollment in STORM-PE clinical trial. The pivotal, ...

BOSTON--(BUSINESS WIRE)--Penumbra, Inc. (NYSE:PEN), a global interventional therapies company, today announced U.S. commercial availability of its most advanced thrombectomy device, the ACE™68 ...